1st edition
Principles of Clinical Cannabinology
A Comprehensive guide to Medical Cannabis in Europe.
Available in both Digital and Print Editions
Your Clinical Compass
600+ Pages of Evidence-Based Clarity
Principles of Cannabinology bridges the gap between raw data and clinical practice. Structured by pathology and anchored in peer-reviewed science, it transforms complex research into actionable therapeutic protocols and regulatory certainty.
1.1 Endocannabinoid System
1.2 Endocannabinoid System and Pain
1.3 The Endocannabinoid System in the Gastrointestinal Tract
1.4 How the Endocannabinoid System regulates sexual activity and birth
1.5 The Endocannabinoid System and the sleep-wake cycle: The role in insomnia
1.6 Insight: Palmitoylethanolamide (PEA)
1.7 Insight: Homeostasis, resilience and the Endocannabinoid System, a holistic approach to mitigate Covid-19 stress
1.8 Insight: The role of the Endocannabinoid System in stress anxiety
2.1 Medical Cannabis: General aspects
2.2 Modes of Use of Medical Cannabis
2.3 Pharmacology of tetrahydrocannabinol (THC). Is it possible to separate the side effects from the therapeutic ones?
2.4 Pharmacology of cannabidiol (CBD)
2.5 Pharmacology of minor phytocannabinoids
2.6 Insight: Cannabis, four new phytocannabinoids identified
2.7 Insight: Guidance on delta-8-THC and delta-10-THC
2.8 Insight: Not only cannabinoids, the link between tryptophan and cannabis
3.1 Pathologies for which cannabis has shown therapeutic efficacy: general aspects
   3.1.1 Insights from MDs: Medical Cannabis for fibromyalgia
   3.1.2 Insights from MDs: chronic pain in adults
   3.1.3 Insights from MDs: chronic pain in the elderly
3.2 Cannabis in neurological and neurodegenerative diseases
   3.2.1 Parkinson’s disease and Cannabis
   3.2.2 Insights from MDs: Medical Cannabis for Pakinson’s disease
   3.2.3 Cannabis for Alzheimer’s and beyond: the clinical protocol in geriatric patients
   3.2.4 Childhood epilepsy, cannabis therapies and CBD side effects
   3.2.5 Insights from MDs: Medical Cannabis for drug-resistant epilepsy in adults
   3.2.6 Cannabis and Multiple Sclerosis: analysis of major clinical studies
   3.2.7 Insights from MDs: Medical Cannabis for Multiple Sclerosis
3.3 Cannabis in disorders of the musculoskeletal system
   3.3.1 Cannabis Medica in orthopaedics: cannabinoids and the musculoskeletal system
   3.3.2 Muscular Dystrophy and Cannabis
   3.3.3 Topical applications of CBD: transdermal patches with muscle relaxants
   3.3.4 CBD in the treatment of low back pain
   3.3.5 Insight: What are the effects of CBD? Is it possible use it in sport?
3.4 Cannabis in cardiovascular disorders
   3.4.1 Cannabis and cardiovascular diseases
   3.4.2 Cannabis and hypertension in elderly patients: a clinical study
   3.4.3 Cannabidiol for infants: ischaemia and
3.5 Cannabis in metabolic disorders
   3.5.1 Cannabis and diabetes: evidence for and against its use
   3.5.2 Cannabis and obesity: the role of THCA
3.6 Dermatological Diseases and the Endocannabinoid System
   3.6.1 Insights from MDs: Medical Cannabis in dermatology
3.7 Cannabis and chronic inflammatory bowel disease (IBD)
   3.7.1 Insights from MDs: Medical Cannabis for Chron disease
3.8 CBD in neuropsychiatry: the effects of Cannabidiol in the brain
   3.8.1 Post-Traumatic Stress and how Cannabis can help
   3.8.2 What is autism and how to treat it with CBD: two case studies from Brazil
   3.8.3 Hands-on experience: CBD in attention deficit hyperactivity disorder (ADHD)
   3.8.4 Insights from MDs: Cannabinoids for Autism and ADHD
3.9 Cannabis and glaucoma
3.10 Mouthwash and Cannabis
3.11 Medical Cannabis and Palliative Care
   3.11.1 Cannabis and glioblastoma: tolerability and efficacy of Sativex®
   3.11.2 Insights from MDs: breast cancer and related comorbidities
   3.11.3 Insights from MDs: Medical Cannabis for esophageal cancer
3.12 Cannabis in the treatment of migraine
3.13 The effects of cannabis and phytocannabinoids on sleep and insomnia
3.14 Drug interaction with cannabinoids
3.15 Insight: Cannabis and cannabigerol (CBG) against antibiotic resistance
3.16 Insight: Cannabis consumption, data from an American study
3.17 Insight: CBD and Covid-19: treating symptoms
3.18 Insight: THC in the treatment of ARDS: possible role in COVID-19 infection?
4.1 Foreword
4.2 Medical Cannabis regulation in Belgium
4.3 Medical Cannabis regulation in Czech Republic
4.4 Medical Cannabis regulation in Denmark
4.6 Medical Cannabis regulation in Germany
4.6 Medical Cannabis regulation in Italy
4.7 Medical Cannabis regulation in Ireland
4.8 Medical Cannabis regulation in Malta
4.9 Medical Cannabis regulation in Poland
4.10 Medical Cannabis regulation in Portugal
4.11 Medical Cannabis regulation in Sweden
4.12 Medical Cannabis regulation in Switzerland
4.13 Medical Cannabis regulation in the UK
Conclusions & Closing Remarks
Product and Legislative Insights on 12 EU Countries
Insights on regulations, insurance reimbursement protocols and available products
Navigate Complexity
with Evidence
Mastering the Essentials
What’s Inside the Blueprint
30+ Pathologies covered
Evidence-Based Therapeutic Areas
From neurodegenerative diseases to complex metabolic disorders. Our manual provides validated clinical protocols and dosage insights for over 30 pathologies, bridging the gap between cannabinoid science and effective patient care.
MUSCULOSKELETAL SYSTEM DISORDERS
CARDIOVASCULAR DISORDERS
METABOLIC DISORDERS
PALLIATIVE CARE
NEUROPSYCHIATRY
IBD
GLAUCOMA
BURNING MOUTH
SKIN DISEASES
MIGRAINE
SLEEP AND INSOMNIA
DRUG INTERACTION
ANTIBIOTIC RESISTANCE
Order your copy
Principles of Clinical Cannabinology
Available in two formats. Both include the complete first edition.
Digital Edition
- Instant PDF download after payment
- Full 5-chapter text, 30+ pathologies
- Searchable - ideal for clinical reference
- Works on any device
- No account required: secure checkout via Stripe
Print Edition
- Printed & bound, professional quality
- Ships via Amazon - tracked delivery
- Ideal for clinic shelves or gifting
- Available across Europe & worldwide
- Fulfilled by Amazon UK

Viola Brugnatelli
Neuroscientist and Founder

Fabio Turco
Neurogastrocannabinologist and Scientific Director
The Authors
The Minds Behind the Principles
A collaboration between clinical expertise and strategic vision. Our authors combine years of peer-reviewed research with real-world medical practice to deliver the definitive standard in cannabinoid science.
Book Contributors
Order Your Copy
Principles of Clinical Cannabinology
Secure your copy of Principles of Clinical Cannabinology and bridge the gap between complex research and daily clinical practice with 600+ pages of peer-reviewed clarity.